Annual Pancreatic Cancer Center Symposium: The Future of Pancreatic Cancer Research

Our new state of the art Pancreatic Cancer Center has been designed to develop novel research with innovation, empowerment, and most importantly, hope. Our pancreatic cancer center combines internationally renowned expertise with leading therapies. We aim to deliver personalized care that helps more patients achieve a renewed sense of wellbeing, and increased survivorship.

We greatly look forward to seeing you in October either in person, or virtually, as you join us on our worthy mission in looking to the future of pancreatic cancer research.

Agenda

Location: Henry Ford Hospital - Education & Research Building – Room 2055 – Detroit, Michigan

Time
Topic/Speaker
Table
8 - 9:00 a.m.
Registration & Welcome Breakfast
Education and Research Building, 7th floor
9 - 9:05 a.m.
Opening Remarks
9:05 - 10:00 a.m.
Keynote Address: Edna Cukierman, Ph.D.
Fox Chase Cancer Center
“Targeting the Pancreatic Cancer Microenvironment”
10:00 - 10:15 a.m. BREAK
10:15 - 10:50 a.m.
Jennifer Bailey, Ph.D.
University of Texas Health Science Center, Houston
“Epithelial plasticity influences adenosine dependent immunosuppression in the pancreatic tumor microenvironment”
10:50 - 11:25 a.m.
Cullen Taniguchi, M.D., Ph.D.
University of Texas MD Anderson Cancer Center
“HIF2-mediated CAF Crosstalk in the Pancreatic Cancer Microenvironment”
11:25 a.m. - 12:00 p.m.
Kathleen DelGiorno, Ph.D.
Vanderbilt University
“Eicosanoids in the pancreatic tumor microenvironment - a multicellular, multi-faceted progression”
12 - 1:00 p.m.
LUNCH
1:00 - 1:45 p.m.
Andrew Aguirre, M.D.,Ph.D.
Dana–Farber Cancer Institute
“Targeting KRAS in pancreatic cancer: challenges and opportunities”
1:45 - 2:20 p.m.
Nina Steele, Ph.D.
Henry Ford Health Pancreatic Cancer Center
“Investigating cellular cross talk in the immunosuppressive pancreatic tumor microenvironment”
2:20 - 2:55 p.m.
Jason Pitarresi, Ph.D.
University of Massachusetts Chan Medical School
“The pleiotropic roles of PTHrP in driving pancreatic cancer cell plasticity and dis-ease phenotypes”
2:55 - 3:05 p.m.
BREAK
3:05 - 3:50 p.m.
Costas Lyssiotis, Ph.D.
University of Michigan Rogel Cancer Center
“Metabolic Networks in the Tumor Microenvironment”
3:50 - 4:25 p.m.
Ling Huang, Ph.D.
Henry Ford Health Pancreatic Cancer Center
“Investigation of cells state alteration in pancreatic tumorigenesis”
4:25 - 5:00 p.m.
Asfar Azmi, Ph.D.
Karmanos Cancer Institute
“Targeting Nuclear Protein Export Signaling in Pancreatic Cancer”
5:00 p.m.
Closing Remarks

Register Now

We are currently offering both in-person and virtual attendance options. In-person registration is limited. Once all of the available in-person openings have been filled, only virtual attendance will be offered.

Please complete the form below to register for the event.

*Asterisk indicates required field.

X

Cookie Consent

We use cookies to improve your web experience. By using this site, you agree to our Terms of Use. Read our Internet Privacy Statement to learn what information we collect and how we use it.

Accept All Cookies